Icon (ICLR) Competitors

Icon logo
$191.40 -3.25 (-1.67%)
Closing price 04:00 PM Eastern
Extended Trading
$191.30 -0.09 (-0.05%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICLR vs. CRL, IQV, A, WAT, and MTD

Should you buy Icon stock or one of its competitors? Icon's main competitors and comparable companies include Charles River Laboratories International (CRL), IQVIA (IQV), Agilent Technologies (A), Waters (WAT), and Mettler-Toledo International (MTD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Icon compare to Charles River Laboratories International?

Charles River Laboratories International (NYSE:CRL) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

Icon has higher revenue and earnings than Charles River Laboratories International. Icon is trading at a lower price-to-earnings ratio than Charles River Laboratories International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charles River Laboratories International$3.98B4.08-$144.34M$0.91371.73
Icon$8.23B1.81$229.34M$5.8133.50

Charles River Laboratories International presently has a consensus price target of $311.67, suggesting a potential downside of 7.86%. Icon has a consensus price target of $213.76, suggesting a potential upside of 9.82%. Given Icon's higher probable upside, analysts clearly believe Icon is more favorable than Charles River Laboratories International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charles River Laboratories International
1 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.71
Icon
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Charles River Laboratories International had 6 more articles in the media than Icon. MarketBeat recorded 9 mentions for Charles River Laboratories International and 3 mentions for Icon. Charles River Laboratories International's average media sentiment score of 0.93 beat Icon's score of 0.65 indicating that Charles River Laboratories International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charles River Laboratories International
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Icon
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Icon has a net margin of 5.45% compared to Charles River Laboratories International's net margin of 1.01%. Charles River Laboratories International's return on equity of 16.95% beat Icon's return on equity.

Company Net Margins Return on Equity Return on Assets
Charles River Laboratories International1.01% 16.95% 6.93%
Icon 5.45%7.73%4.39%

98.9% of Charles River Laboratories International shares are held by institutional investors. Comparatively, 95.6% of Icon shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by insiders. Comparatively, 44.0% of Icon shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Charles River Laboratories International has a beta of 1.36, suggesting that its share price is 36% more volatile than the broader market. Comparatively, Icon has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market.

Summary

Charles River Laboratories International beats Icon on 10 of the 17 factors compared between the two stocks.

How does Icon compare to IQVIA?

Icon (NASDAQ:ICLR) and IQVIA (NYSE:IQV) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

IQVIA has higher revenue and earnings than Icon. IQVIA is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Icon$8.23B1.81$229.34M$5.8133.50
IQVIA$17.31B2.53$1.36B$8.2332.25

In the previous week, IQVIA had 4 more articles in the media than Icon. MarketBeat recorded 7 mentions for IQVIA and 3 mentions for Icon. IQVIA's average media sentiment score of 0.82 beat Icon's score of 0.65 indicating that IQVIA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Icon
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IQVIA
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Icon currently has a consensus price target of $213.76, indicating a potential upside of 9.82%. IQVIA has a consensus price target of $294.21, indicating a potential upside of 10.84%. Given IQVIA's stronger consensus rating and higher possible upside, analysts plainly believe IQVIA is more favorable than Icon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Icon
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.50
IQVIA
1 Sell rating(s)
2 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
2.90

IQVIA has a net margin of 8.05% compared to Icon's net margin of 5.45%. IQVIA's return on equity of 30.02% beat Icon's return on equity.

Company Net Margins Return on Equity Return on Assets
Icon5.45% 7.73% 4.39%
IQVIA 8.05%30.02%6.52%

Icon has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, IQVIA has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market.

95.6% of Icon shares are held by institutional investors. Comparatively, 89.6% of IQVIA shares are held by institutional investors. 44.0% of Icon shares are held by insiders. Comparatively, 1.7% of IQVIA shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

IQVIA beats Icon on 13 of the 17 factors compared between the two stocks.

How does Icon compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Agilent Technologies presently has a consensus target price of $181.45, suggesting a potential upside of 4.29%. Icon has a consensus target price of $213.76, suggesting a potential upside of 9.82%. Given Icon's higher possible upside, analysts plainly believe Icon is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilent Technologies
0 Sell rating(s)
4 Hold rating(s)
18 Buy rating(s)
0 Strong Buy rating(s)
2.82
Icon
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Agilent Technologies had 7 more articles in the media than Icon. MarketBeat recorded 10 mentions for Agilent Technologies and 3 mentions for Icon. Icon's average media sentiment score of 0.65 beat Agilent Technologies' score of 0.46 indicating that Icon is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilent Technologies
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Icon
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Agilent Technologies has higher earnings, but lower revenue than Icon. Icon is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilent Technologies$7.37B6.65$1.30B$5.0834.25
Icon$8.23B1.81$229.34M$5.8133.50

Agilent Technologies has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market. Comparatively, Icon has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market.

Agilent Technologies has a net margin of 19.53% compared to Icon's net margin of 5.45%. Agilent Technologies' return on equity of 24.45% beat Icon's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilent Technologies19.53% 24.45% 13.09%
Icon 5.45%7.73%4.39%

87.4% of Agilent Technologies shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 0.2% of Agilent Technologies shares are owned by insiders. Comparatively, 44.0% of Icon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Agilent Technologies beats Icon on 10 of the 17 factors compared between the two stocks.

How does Icon compare to Waters?

Waters (NYSE:WAT) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

Waters has higher earnings, but lower revenue than Icon. Icon is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Waters$3.17B14.29$642.63M$2.33197.51
Icon$8.23B1.81$229.34M$5.8133.50

Waters currently has a consensus price target of $475.48, suggesting a potential upside of 3.32%. Icon has a consensus price target of $213.76, suggesting a potential upside of 9.82%. Given Icon's higher possible upside, analysts plainly believe Icon is more favorable than Waters.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Waters
0 Sell rating(s)
6 Hold rating(s)
17 Buy rating(s)
1 Strong Buy rating(s)
2.79
Icon
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Waters had 16 more articles in the media than Icon. MarketBeat recorded 19 mentions for Waters and 3 mentions for Icon. Icon's average media sentiment score of 0.65 beat Waters' score of 0.36 indicating that Icon is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Waters
5 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral
Icon
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

94.0% of Waters shares are held by institutional investors. Comparatively, 95.6% of Icon shares are held by institutional investors. 0.3% of Waters shares are held by insiders. Comparatively, 44.0% of Icon shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Waters has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market. Comparatively, Icon has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

Icon has a net margin of 5.45% compared to Waters' net margin of 1.75%. Waters' return on equity of 9.91% beat Icon's return on equity.

Company Net Margins Return on Equity Return on Assets
Waters1.75% 9.91% 6.11%
Icon 5.45%7.73%4.39%

Summary

Waters and Icon tied by winning 8 of the 16 factors compared between the two stocks.

How does Icon compare to Mettler-Toledo International?

Icon (NASDAQ:ICLR) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

Icon currently has a consensus price target of $213.76, indicating a potential upside of 9.82%. Mettler-Toledo International has a consensus price target of $1,595.77, indicating a potential downside of 8.20%. Given Icon's stronger consensus rating and higher probable upside, analysts clearly believe Icon is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Icon
1 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.50
Mettler-Toledo International
1 Sell rating(s)
8 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.33

Icon has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.16, meaning that its stock price is 16% more volatile than the broader market.

Mettler-Toledo International has a net margin of 22.25% compared to Icon's net margin of 5.45%. Mettler-Toledo International's return on equity of 15,012.71% beat Icon's return on equity.

Company Net Margins Return on Equity Return on Assets
Icon5.45% 7.73% 4.39%
Mettler-Toledo International 22.25%15,012.71%25.41%

Mettler-Toledo International has lower revenue, but higher earnings than Icon. Icon is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Icon$8.23B1.81$229.34M$5.8133.50
Mettler-Toledo International$4.03B8.59$869.19M$46.1537.67

95.6% of Icon shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 44.0% of Icon shares are owned by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Mettler-Toledo International had 24 more articles in the media than Icon. MarketBeat recorded 27 mentions for Mettler-Toledo International and 3 mentions for Icon. Mettler-Toledo International's average media sentiment score of 0.76 beat Icon's score of 0.65 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Icon
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mettler-Toledo International
11 Very Positive mention(s)
2 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Mettler-Toledo International beats Icon on 9 of the 17 factors compared between the two stocks.

Get Icon News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICLR vs. The Competition

MetricIconLife Sciences Tools & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$14.65B$10.83B$7.83B$11.76B
Dividend YieldN/A1.45%2.47%4.41%
P/E Ratio32.9451.4934.3230.12
Price / Sales1.787.118.005.33
Price / Cash11.5526.7921.0222.32
Price / Book1.595.804.763.85
Net Income$229.34M$57.47B$3.52B$391.27M
7 Day Performance-7.80%-5.43%-5.35%-4.55%
1 Month Performance12.47%-0.97%-3.62%-5.89%
1 Year Performance18.02%18.51%-0.62%-7.84%

Icon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICLR
Icon
3.8166 of 5 stars
$191.40
-1.7%
$213.76
+11.7%
+20.0%$14.65B$8.23B32.9440,100
CRL
Charles River Laboratories International
2.3876 of 5 stars
$354.45
+5.0%
$308.17
-13.1%
+101.8%$15.58B$4.02B389.5119,700
IQV
IQVIA
3.8324 of 5 stars
$278.84
+2.6%
$294.21
+5.5%
+20.1%$43.47B$16.31B22.7893,000
A
Agilent Technologies
3.7705 of 5 stars
$180.09
+3.0%
$181.45
+0.8%
+18.4%$49.95B$6.95B35.4518,100
WAT
Waters
2.2872 of 5 stars
$477.12
+4.3%
$475.48
-0.3%
+21.1%$45.94B$3.17B204.777,900

Related Companies and Tools


This page (NASDAQ:ICLR) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners